Symptomatic and asymptomatic long-term recurrences following transcatheter atrial fibrillation ablation

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 6, 2014, Pages 697-702

  Manganiello, Sabrina ^a   Anselmino, Matteo ^a   Amellone, Claudia ^b   Pelissero, Elisa ^a   Giuggia, Marco ^b   Trapani, Giuseppe ^b   Giordano, Benedetta ^b   Senatore, Gaetano ^b   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Nephrology and Dialysis Unit Cirié Hospital   (Italy)

Author keywords

asymptomatic recurrences; paroxysmal and persistent atrial fibrillation; transcatheter ablation

Indexed keywords

AMIODARONE; FLECAINIDE; HEPARIN; SOTALOL; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOME MONITORING; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREDICTIVE VALUE; PREOPERATIVE CARE; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RELAPSE; TRANSCATHETER ABLATION; ATRIAL FIBRILLATION; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; INCIDENCE; ITALY; LONGITUDINAL STUDY; MIDDLE AGED; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RECURRENCE; RISK ASSESSMENT; SYMPTOM ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84902545936     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12387     Document Type: Article

References (17)

1. Kaufman ES, Waldo AL,. The impact of asymptomatic atrial fibrillation. J Am Coll Cardiol 2004; 43: 53-54.
2. Piorkowski C, Kottkamp H, Tanner H, Kobdza R, Cosedis Nielsen J, Arya A, Hindricks G,. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16: 1286-1292.
3. Martinek M, Aichinger J, Nesser HJ, Ziegler PD, Purerfellner H,. New insights into long-term follow-up of atrial fibrillation ablation: Full disclosure by an implantable pacemaker device. J Cardiovasc Electrophysiol 2007; 18: 818-823.
4. Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, et al. Twenty-four-hour Holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation 2009; 120 (11 Suppl): S177-S184.
5. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: Crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-248.
6. Ziegler PD, Koehler JL, Mehra R,. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006; 3: 1445-1452.
7. Camm AJ, Corbucci G, Padeletti L,. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 2012; 110: 270-276.
8. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Eur Heart J 2010; 31: 2369-2429.
9. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, et al. XPECT trial investigators. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrhythm Electrophysiol 2010; 3: 141-147.
10. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, Lellouche N, et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
11. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, Neven K, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
12. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, Coin D, et al. Long-term clinical results of two different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythmia Electrophysiol 2008; 1: 269-275.
13. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R,. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004; 35: 1647-1651.
14. Pontoppidan J, Nielsen JC, Poulsen SH, Hansen PS,. Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life. Pacing Clin Electrophysiol 2009; 32: 717-726.
15. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H,. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313.
16. Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, Morillo CA, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF) J Am Med Assoc Intern Med 2013; 173: 149-156.
17. Jung W, Zvereva V, Rilling A, Roggenbuck B, Sadeghzadeh G, Kholer J,. How to use implantable loop recorders in clinical trials and hybrid therapy. J Interv Card Electrophysiol 2011; 32: 227-232.